Airway epithelial cells and asthma: from barrier disruption to alarmin-driven inflammation and remodeling.
- 1The First Hospital of China Medical University, Shenyang, China.
- 2Shengjing Hospital of China Medical University, Shenyang, China. [email protected].
Abstract
Asthma is a highly heterogeneous chronic inflammatory airway disease whose pathophysiology is determined by a combination of genetic, environmental, and immune factors. As the largest interface between the host and the environment, airway epithelial cells serve not only as a physical barrier against exogenous stimuli but also as central cells in sensing environmental threats and initiating immune responses. Among their functions, the release of epithelial-derived alarmins is a key step in initiating type 2 inflammation. Under the long-term interaction of genetic susceptibility and environmental factors, persistent structural and functional alterations occur in the airway epithelium of asthma patients. These include disruption of the barrier integrity, skewed cell differentiation, aberrant repair programs, and dysregulated alarmin release. These alterations not only exacerbate airway inflammation but can also directly drive the process of airway remodeling through mechanisms such as epithelial-mesenchymal transition, ciliary dysfunction, mucus hypersecretion, and paracrine regulation of smooth muscle. Remodeling also involves biochemical and mechanical alterations, including dysregulated expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), increased extracellular matrix (ECM) stiffness, and enhanced collagen crosslinking. Given the central role of the airway epithelium in asthma pathogenesis, targeting its alarmins and related signaling pathways holds promise for providing precise intervention strategies for patients with specific endotypes. This article systematically reviews the structural and functional changes in the asthmatic airway epithelium, analyzes the intrinsic links between barrier dysfunction, alarmin release, and airway pathological changes, and summarizes recent advances in interventions targeting the airway epithelium, aiming to provide a new theoretical basis for the precise diagnosis and treatment of asthma.
Related
- Blocking IL-6 trans-signaling mitigates benzalkonium chloride-induced inflammation, oxidative imbalance, ER stress, and barrier disruption in human corneal epithelial cells.
- Anti-Nectin4 monoclonal antibodies attenuate airway inflammation and epithelial barrier dysfunction in asthma
- Malus domestica fruit-derived vesicles extract protect against upstream cellular hallmarks of vascular inflammation and epithelial barrier dysfunction
- Beyond the Alarmin: Nuclear Interleukin-33 and Skin Barrier Dysfunction in Atopic Dermatitis
- GPR84 exacerbates blood-brain barrier disruption after ischemic stroke via cAMP/CREB-dependent tight junction suppression
BibTeX
@article{xu2026airway,
title = {{Airway epithelial cells and asthma: from barrier disruption to alarmin-driven inflammation and remodeling.}},
author = {Xiwen Xu and Bowen Zhang},
journal = {Cell division},
year = {2026},
month = aug,
doi = {10.1186/s13008-026-00193-1},
url = {https://europepmc.org/article/MED/42963782},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Airway epithelial cells and asthma: from barrier disruption to alarmin-driven inflammation and remodeling.
AU - Xiwen Xu
AU - Bowen Zhang
PY - 2026
DA - 2026/08/04
JO - Cell division
DO - 10.1186/s13008-026-00193-1
UR - https://europepmc.org/article/MED/42963782
AB - Asthma is a highly heterogeneous chronic inflammatory airway disease whose pathophysiology is determined by a combination of genetic, environmental, and immune factors. As the largest interface between the host and the environment, airway epithelial cells serve not only as a physical barrier against exogenous stimuli but also as central cells in sensing environmental threats and initiating immune responses. Among their functions, the release of epithelial-derived alarmins is a key step in initiating type 2 inflammation. Under the long-term interaction of genetic susceptibility and environmental factors, persistent structural and functional alterations occur in the airway epithelium of asthma patients. These include disruption of the barrier integrity, skewed cell differentiation, aberrant repair programs, and dysregulated alarmin release. These alterations not only exacerbate airway inflammation but can also directly drive the process of airway remodeling through mechanisms such as epithelial-mesenchymal transition, ciliary dysfunction, mucus hypersecretion, and paracrine regulation of smooth muscle. Remodeling also involves biochemical and mechanical alterations, including dysregulated expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), increased extracellular matrix (ECM) stiffness, and enhanced collagen crosslinking. Given the central role of the airway epithelium in asthma pathogenesis, targeting its alarmins and related signaling pathways holds promise for providing precise intervention strategies for patients with specific endotypes. This article systematically reviews the structural and functional changes in the asthmatic airway epithelium, analyzes the intrinsic links between barrier dysfunction, alarmin release, and airway pathological changes, and summarizes recent advances in interventions targeting the airway epithelium, aiming to provide a new theoretical basis for the precise diagnosis and treatment of asthma.
SN - 1747-1028
ER -